Thiola® EC (tiopronin) – New formulation approval
June 28, 2019 - Retrophin announced the FDA approval of Thiola EC (tiopronin) delayed-release tablets, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.
Top